Dr. Colm Henry:

I agree completely. One of the valuable resources for us, in working through the valproate project, was working with community pharmacists who are in a unique position in terms of access to women who are at risk for valproate exposure in pregnancy because such women are known to them. I definitely see a role for them in this programme, which is headed by Dr. Colin Doherty. I will talk to him about how we can use community pharmacists to best effect.